deoxypyridinoline

网络  和脱氧吡啶啉; 脱氧吡啶啉; 吡啶龙; 脱氧比林二酚胺; 脱氧吡啶诺林

医学



双语例句

  1. Objective To evaluate the clinical significance of pyridinoline ( PYD) and deoxypyridinoline ( DPD) in patients with cancer.
    目的评价尿吡啶酚和脱氧吡啶酚对恶性肿瘤骨转移患者的临床意义。
  2. Objective To study diagnostic value of urine deoxypyridinoline to gestational low bone mass.
    目的探讨尿脱氧吡啶酚排泄率对妊娠性骨量减少的诊断意义。
  3. Objective To investigate the diagnostic value of excretion rate of deoxypyridinoline ( DPD) in urine and bone-specific alkaline phosphatase ( BAP) in serum for osteoporosis and the correlation between the 2 indexes.
    目的探讨尿脱氧吡啶啉(DPD)排泄率及骨源性碱性磷酸酶(BAP)对骨质疏松症患者的诊断价值及两者的相关性。
  4. Evaluation of Detection of Urinary Deoxypyridinoline for Bone Absorption in Asthma Treated with Glucocorticoid Hormone
    尿脱氧吡啶啉检测对激素治疗哮喘患者骨吸收的评价
  5. Urinary Deoxypyridinoline ( DPD), Serum Bone Glia Protein ( BGP) and Bone Metabolism Change in Hyperthyroidism
    甲亢患者尿DPD、血清BGP水平变化与骨代谢的关系
  6. Objective To observe the changes of urinary deoxypyridinoline crosslink/ creatinine ( UDpd/ Cr) in rats after OVX and intervention by estrogen and bisphosphonate and investigate the possible application of deoxypyridinoline in osteoporosis diagnosis and treatment.
    目的观察大鼠去卵巢及予以不同的干预后尿脱氧吡啶啉/肌酐比率(urinarydeoxypyridinolinecrosslink/creatinine,UDpd/Cr)的变化,了解其在骨质疏松的诊断和治疗中的应用价值。
  7. Clinic significance of urinary deoxypyridinoline and bone alkaline phosphatase in osteoporosis
    尿脱氧吡啶啉及骨源性碱性磷酸酶在骨质疏松症中的临床意义
  8. Indexes of bone-specific alkaline phosphatase ( BAP) and deoxypyridinoline crosslinks ( DPD) of the rats serum, which could show the growth and function of osteoblast and osteoclast were tested.
    检测成骨细胞、破骨细胞的生长和功能的指标-骨碱性磷酸酶及尿脱氧吡啶交联水平。
  9. Combined determination of urinary deoxypyridinoline and bone alkaline phosphatase and its diagnostic value for osteoporosis
    联合检测尿脱氧吡啶啉与骨源性碱性磷酸酶诊断骨质疏松症
  10. Conclusions Urine deoxypyridinoline is a convenient biochemical marker sensitive in predict-ing the increase of bone resorption in women during their gestation and lactation.
    结论尿脱氧吡啶酚排泄率可作为反映妊娠期和哺乳期骨吸收增加的方便、灵敏、特异的生化指标。
  11. Clinical value of urinary deoxypyridinoline excretion in postmenopausal osteoporosis
    尿脱氧吡啶啉排泄率在绝经后骨质疏松症中的临床监测意义
  12. Objective: To explore the clinical value of bone metabolic markers osteocalcin ( BGP) and deoxypyridinoline ( DPD) in multiple myeloma ( MM).
    目的:了解骨代谢指标骨钙素(BGP)和游离脱氧吡啶(DPD)在多发性骨髓瘤(MM)中的含量变化,探讨BGP和DPD在MM患者诊断和治疗方面的意义。
  13. Clinical significance of urinary deoxypyridinoline in patient with bone metastases from lung cancer
    尿脱氧吡啶酚在肺癌骨转移中的临床意义
  14. Objective To investigate the relationship between the content of deoxypyridinoline ( DPD) in urine and the experimental osteoporosis in rats.
    目的研究尿脱氧吡啶酚(DPD)含量变化与大鼠发生实验性骨质疏松的相关性,探讨尿脱氧吡啶酚在骨质疏松防治研究中的意义。